GL1X · GenesisL1 explorer

MolNFT v1 · #167127 · protein

Crystal structure of PDE5 in complex with a non-competitive inhibitor

6VBI · Cgmp-specific 3',5'-cyclic phosphodiesterase: “Crystal structure of PDE5 in complex with a non-competitive inhibitor”. X-ray diffraction, 1 ligand (FZA), 5 pockets (best druggability 0.83). MolNFT v1 #167127 on GenesisL1: 3D…

PDB
6VBI
Type
protein
Length
605 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Cgmp-specific 3',5'-cyclic phosphodiesterase
EC
3.1.4.35
UniProt
O76074
Ligands
FZA
Pockets
5 · best druggability 0.83

Structure

x-ray diffraction · 2 distinct chains · 66% helix, 0% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ACgmp-specific 3',5'-cyclic phosphodiesterase (EC 3.1.4.35)protein30465% helix, 0% strandO76074
BCgmp-specific 3',5'-cyclic phosphodiesterase (EC 3.1.4.35)protein30166% helix, 0% strandO76074

Ligands and binding sites

  • FZA · (13bS)-4,9-dimethoxy-14-methyl-8,13,13b,14-tetrahydroindolo[2',3':3,4]pyrido[2,1-b]quinazolin-5(7H)-one · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
17950.830.8697FZA
22560.770.9039FZA
3720.580.8919empty
41150.400.7516empty
51250.380.7328empty

Interfaces

1 interface between chains.

  • A–B · 1189 Ų buried · 14 hydrogen bonds · protein-protein

Compared structures

  • 6VBI · crystal structure of PDE5 in complex with a non-competitive inhibitor · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.